Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 14, 2012; 18(38): 5397-5403
Published online Oct 14, 2012. doi: 10.3748/wjg.v18.i38.5397
Published online Oct 14, 2012. doi: 10.3748/wjg.v18.i38.5397
Figure 1 Study flow of the screening and referral cohort compared in the present study.
1This includes cases in which an incomplete initial colonoscopy was followed by a second complete colonoscopy, virtual colonoscopy or x-colon. FIT: Fecal immunochemical test; CRC: Colorectal cancer; IBD: Inflammatory bowel disease.
Figure 2 Colorectal cancer tumor stage distribution in screening (n = 28) and referral (n = 90) populations in studies on diagnostic performance of an fecal immunochemical test.
Difference between screening and referral P < 0.001.
- Citation: van Turenhout ST, van Rossum LG, Oort FA, Laheij RJ, van Rijn AF, Terhaar sive Droste JS, Fockens P, van der Hulst RW, Bouman AA, Jansen JB, Meijer GA, Dekker E, Mulder CJ. Similar fecal immunochemical test results in screening and referral colorectal cancer. World J Gastroenterol 2012; 18(38): 5397-5403
- URL: https://www.wjgnet.com/1007-9327/full/v18/i38/5397.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i38.5397